Is There a Role for VATS Sleeve Lobectomy in Lung Cancer?

Natalie N. Merchant, Robert McKenna, Osita Onugha

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Lung cancer is the second most commonly diagnosed cancer and continues to be the leading cause of death for both men and women, with non-small cell lung cancer (NSCLC) accounting for 85% of all lung cancer cases. Once a lung mass is visualized on imaging, accurate staging is required for determination of treatment options and, when possible, surgical resection is recommended as it has been proven to have the best survival rates versus non-surgical treatment. If a patient has advanced or metastatic disease, therapeutic options include chemotherapy and radiation, while immunotherapy and specific agents that target tumor mutations are only recommended for appropriate candidates. Additionally, surgical options differ based on whether the tumor is peripherally or centrally located in the lung parenchyma. This article will review relevant literature concerning current surgical techniques for resection of centrally located NSCLC using thoracotomy and will emphasize the benefits and challenges of a video-assisted thoracic surgery (VATS) approach.

Original languageEnglish
Pages (from-to)225-229
Number of pages5
JournalSurgical technology international
Volume32
StatePublished - Jun 1 2018

Fingerprint

Dive into the research topics of 'Is There a Role for VATS Sleeve Lobectomy in Lung Cancer?'. Together they form a unique fingerprint.

Cite this